Per-Olof Berggren Selected Research

AMP-Activated Protein Kinases

12/2017	Inhibition of C1-Ten PTPase activity reduces insulin resistance through IRS-1 and AMPK pathways.
1/2016	The imidazoline compound RX871024 promotes insulinoma cell death independent of AMP-activated protein kinase inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Per-Olof Berggren Research Topics

Disease

19	Insulin Resistance 01/2023 - 09/2010
18	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2002
13	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 07/2004
11	Inflammation (Inflammations) 06/2022 - 09/2010
10	Obesity 01/2023 - 09/2010
7	Hyperglycemia 01/2020 - 08/2005
7	Neoplasms (Cancer) 01/2020 - 04/2009
5	Hypoglycemia (Reactive Hypoglycemia) 01/2016 - 08/2003
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 01/2013
4	Hypoxia (Hypoxemia) 01/2022 - 01/2018
4	Metabolic Diseases (Metabolic Disease) 01/2021 - 01/2014
4	Hyperinsulinism (Hyperinsulinemia) 12/2019 - 05/2008
4	Diabetes Mellitus 09/2018 - 12/2002
4	Insulinoma 01/2016 - 05/2002
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 04/2009
3	Glucose Intolerance 04/2016 - 07/2014
2	Weight Gain 01/2023 - 01/2018
2	Acute Kidney Injury (Acute Renal Failure) 04/2022 - 11/2021
2	Prediabetic State (Prediabetes) 03/2022 - 06/2011
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022 - 04/2016
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 03/2013
2	Muscular Atrophy (Muscle Atrophy) 12/2017 - 04/2013
2	Blindness (Hysterical Blindness) 12/2016 - 01/2016
2	Body Weight (Weight, Body) 01/2013 - 09/2010
1	Wounds and Injuries (Trauma) 11/2022
1	Periodontal Diseases (Periodontal Disease) 06/2022
1	Morbid Obesity 01/2022
1	Pancreatitis 01/2022
1	Adenoviridae Infections (Adenovirus Infections) 10/2020
1	Congenital Abnormalities (Deformity) 01/2020
1	Overweight 01/2019
1	Mental Disorders (Mental Disorder) 01/2018

Drug/Important Bio-Agent (IBA)

30	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2002
23	Insulin (Novolin)FDA Link 01/2020 - 07/2004
8	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2010
7	CytokinesIBA 06/2022 - 09/2006
6	Apolipoprotein C-IIIIBA 01/2023 - 07/2004
5	Glucagon (Glukagon)FDA Link 01/2020 - 06/2008
4	Adenosine Triphosphate (ATP)IBA 01/2020 - 04/2009
3	Blood Glucose (Blood Sugar)IBA 01/2020 - 01/2016
3	LipidsIBA 01/2019 - 03/2010
3	ApolipoproteinsIBA 01/2017 - 06/2011
3	ImidazolinesIBA 01/2016 - 01/2002
3	Nonesterified Fatty Acids (NEFA)IBA 09/2015 - 04/2015
2	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 06/2022
2	HydrogelsIBA 11/2022 - 06/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2022 - 01/2022
2	A-Form DNA (A-DNA)IBA 04/2022 - 11/2021
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2019
2	Capsules (Microcapsules)IBA 01/2022 - 08/2005
2	Biomarkers (Surrogate Marker)IBA 12/2021 - 08/2015
2	Oxygen (Dioxygen)IBA 01/2020 - 01/2018
2	Estrogens (Estrogen)FDA Link 01/2019 - 01/2013
2	Estrogen Receptor alphaIBA 01/2019 - 01/2013
2	Insulin Receptor Substrate ProteinsIBA 12/2017 - 04/2013
2	AMP-Activated Protein KinasesIBA 12/2017 - 01/2016
2	Protein Tyrosine PhosphatasesIBA 12/2017 - 04/2013
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2017 - 09/2010
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2017 - 09/2015
2	nephrinIBA 04/2016 - 01/2010
2	CholesterolIBA 09/2015 - 01/2013
2	Amino Acids FDA Link 12/2014 - 05/2002
2	LeptinIBA 12/2013 - 07/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2009 - 09/2006
1	Triglycerides (Triacylglycerol)IBA 01/2023
1	Interleukin-33IBA 11/2022
1	AntioxidantsIBA 11/2022
1	Interleukin-10 (Interleukin 10)IBA 06/2022
1	Uric Acid (Urate)IBA 03/2022
1	AdipokinesIBA 01/2022
1	AdiponectinIBA 01/2022
1	2- amino- 3- (4'- N,N- bis(2- chloroethyl)amino)phenylpropionic acid N-oxideIBA 01/2022
1	NPHS2 proteinIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2021
1	Insulin ReceptorIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Antiviral Agents (Antivirals)IBA 11/2020
1	RotenoneIBA 10/2020
1	Streptozocin (Streptozotocin)FDA Link 01/2020
1	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 12/2019
1	Macrophage Colony-Stimulating FactorIBA 12/2019
1	Clodronic Acid (Clodronate)IBA 12/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2019
1	CarbohydratesIBA 01/2019
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2019
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2019
1	PolyphenolsIBA 09/2018
1	Fenofibrate (CiL)FDA LinkGeneric 09/2018
1	KynurenineIBA 01/2018
1	Kynurenic Acid (Kynurenate)IBA 01/2018
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2018
1	Tryptophan (L-Tryptophan)FDA Link 01/2018

Therapy/Procedure

6	Transplantation 10/2020 - 08/2005
3	Immunotherapy 06/2022 - 01/2020
3	Therapeutics 01/2021 - 08/2005
2	Glycemic Control 01/2017 - 04/2015
2	Intraperitoneal Injections 08/2015 - 03/2010
1	Bariatric Surgery 01/2022
1	Islets of Langerhans Transplantation 01/2020